IRIDEX Corporation IRIX
0.72 USD +0.04 (+6.56%)
Nov 9, 2026, 12:07 PM EST
0.66 Day range 0.72
0.61 52-week range 1.65
- YTD
- -36.84%
- 1 year
- -32.08%
News
globenewswire.com Iridex to Report Third Quarter 2026 Financial Results on November 17, 2026 SAN JOSE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the…
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers SciSparc (NASDAQ:SPRC) shares moved upwards by 39.4% to $1.52 during Monday's pre-market session. Xencor (NASDAQ:XNCR) stock moved upwards by 29.46% to $32.6. The company's market cap stands…
benzinga.com Iridex Announces Publication Of 2-Yr Clinical Study Demonstrating Favorable Outcomes With TLT Using MicroPulse Technology In Patients With Primary Glaucoma Iridex Corporation (NASDAQ:IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers ZeroStack (NASDAQ:ZSTK) stock increased by 440.2% to $9.94 during Wednesday's regular session. The company's market cap stands at $4.4 million. Tenon Medical (NASDAQ:TNON) shares moved…
benzinga.com Full Transcript: Iridex Q2 2026 Earnings Call Iridex (NASDAQ:IRIX) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts…
benzinga.com Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
benzinga.com Iridex Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $12.566M Miss $13.587M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is a 16.67 percent decrease over losses of $(0.06) per…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
- benzinga.com Iridex Expands Its EyeProGPO Product Offering To Include The Company’s Line Of EndoProbe Handpieces Through the agreement, more than 4,300 EyeProGPO members will have access to preferred pricing on Iridex EndoProbe Handpieces, expanding the value Iridex provides to ophthalmology practices,…
- benzinga.com Iridex Q1 2026 Earnings Call: Complete Transcript
benzinga.com Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.- benzinga.com Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per…
benzinga.com Earnings Scheduled For May 19, 2026 - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Iridex Q4 EPS $(0.01) Beats $(0.02) Estimate, Sales $14.724M Miss $14.740M Estimate. Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 80 percent increase over losses of $(0.05) per share…- benzinga.com Earnings Scheduled For March 26, 2026
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Iridex Reports Preliminary Q4 2025 Revenue Of $14.6M–$14.8M, Up 15%–17% YoY, And Full-Year Revenue Of $52.5M–$52.7M, Up 8% YoY, While Achieving Positive Cash Flow And Adjusted EBITDA Fourth Quarter 2025 ResultsTotal revenue is expected to be between $14.6 million and $14.8 million compared to $12.7 million in the prior year quarter, representing year-over-year growth between 15%…- benzinga.com New Study Shows Iridex Laser Treatment Safely Lowers Eye Pressure for Glaucoma Patients Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket 
benzinga.com Iridex Q3 EPS $(0.09) Up From $(0.12) YoY, Sales $12.484M Up From $11.581M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.09) per share. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company reported $12.484…
benzinga.com Earnings Scheduled For November 11, 2025 
benzinga.com Earnings Scheduled For August 12, 2025 - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com Earnings Scheduled For May 13, 2025
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Earnings Scheduled For March 27, 2025
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Earnings Scheduled For November 12, 2024
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com Earnings Scheduled For March 26, 2024 Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.
- benzinga.com Earnings Scheduled For November 14, 2023 Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue of $18.00 million.
- benzinga.com Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Gainers
- benzinga.com Stocks That Hit 52-Week Lows On Friday During the Friday's sesion, 157 stocks hit new 52-week lows.
- benzinga.com Earnings Scheduled For August 10, 2023 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 32 companies reached new 52-week lows.
- benzinga.com Earnings Scheduled For May 11, 2023 Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its…
- benzinga.com Earnings Scheduled For March 9, 2023 Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 10, 2022 Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 85 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 96 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 507 stocks hit new 52-week lows.